CN1899402A - Chinese medicine capsule for treating cervical spondylosis - Google Patents

Chinese medicine capsule for treating cervical spondylosis Download PDF

Info

Publication number
CN1899402A
CN1899402A CNA2006100484043A CN200610048404A CN1899402A CN 1899402 A CN1899402 A CN 1899402A CN A2006100484043 A CNA2006100484043 A CN A2006100484043A CN 200610048404 A CN200610048404 A CN 200610048404A CN 1899402 A CN1899402 A CN 1899402A
Authority
CN
China
Prior art keywords
grams
gram
chinese medicine
cervical spondylosis
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2006100484043A
Other languages
Chinese (zh)
Other versions
CN100459989C (en
Inventor
张燕荣
张思生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2006100484043A priority Critical patent/CN100459989C/en
Publication of CN1899402A publication Critical patent/CN1899402A/en
Application granted granted Critical
Publication of CN100459989C publication Critical patent/CN100459989C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention is a kind of Chinese medicine capsule for treating cervical spondylosis. The Chinese medicine capsule is prepared with long-noded pit viper, angelica, clematis root, myrrh, dahurian angelica root and other six kinds of Chinese medicinal materials, and through crushing into powder, encapsulating and other steps. The present invention has reasonable recipe, high curative effect and low cost.

Description

The Chinese medicinal capsule of treatment cervical spondylosis
One, technical field
The present invention relates to a kind of Chinese medicine, particularly a kind of Chinese medicinal capsule for the treatment of cervical spondylosis.
Two, background technology
Cervical spondylosis is meant the cervical intervertebral disk degeneration and causes spinal cord, nerve, blood vessel pressurized, infringement and the corresponding sings and symptoms that causes that patient age is many more than 40 years old, and is in the majority with the male.Its cause of disease mainly is the cervical intervertebral disk degeneration, and acute or chronic injury also can bring out cervical spondylosis.
Cervical spondylosis is a kind of common frdquently encountered disease, according to the cervical vertebra incidence, be divided into the nervous system type cervical spondylosis, cervical spondylotic myelopathy, sympathetic cervical spondylosis and vertebral artery type of cervical spondylosis etc., clinical surface mostly is dizzy, neck, shoulder, arm, hands pain, symptomes complices such as numbness, so cervical spondylosis claims cervical vertebra syndrome again, have a strong impact on the healthy of people and work, orthobiosiss such as study and work, the treatment cervical spondylosis has operative treatment at present, non-operative treatment and Drug therapy etc., for various reasons, present above-mentioned treatment is all unsatisfactory, and treatment and drug administration process time are long, expense is many, trouble, and curative effect is low.
Three, summary of the invention
At above-mentioned situation, the present invention's purpose just provides a kind of Chinese medicinal capsule of new treatment cervical spondylosis, can effectively solve the trouble and the low problem of curative effect of treatment cervical spondylosis, the present invention is achieved like this, according to the interrelated data record, the reason of cervical spondylosis: endogenous cause of ill is in congenital malformation, caused by liver and kidney deficiency; Exopathogenic factor is because of acute cervical spinal injury, chronic strain, wind-cold damp pathogen, and the acute inflammation around the neck all can cause the generation of primary disease.Chinese medicine thinks that the skeleton of suffering from a deficiency of the kidney first loses supports, gas, blood, expectorant, arthralgia due to blood stasis resistance passages through which vital energy circulates.The skeleton of suffering from a deficiency of the kidney then loses in moistening foster, gives birth in the hyperosteogeny, causes injury of tendon and muscle flesh and decreases, and of a specified duration is blood-stasis internal-depression; Second blood operation in Tianjin is unable, and stopping coacervation is phlegm-turbidity and blood stasis blood, the obstruction of meridian circulation, and dignified with the passing of time hyperosteogeny is living.Primary disease is levying of deficiency in origin and excess in superficiality, die and consolidate it with the kidney invigorating, control its mark with blood circulation promoting and blood stasis dispelling, channels sootheing and network vessel quickening, and as the principles of formulating prescriptions, the Chinese crude drug that adopts Agkistrodon, Radix Angelicae Sinensis, Radix Clematidis, Myrrha, the Radix Angelicae Dahuricae, Radix Puerariae, eupolyphaga, Lignum Dalbergiae Odoriferae, Rhizoma Chuanxiong, Scolopendra and Impatientis to cook by the conventional process of preparing Chinese medicine of Chinese medicine requirement, through the science compatibility, be ground into powder and incapsulate and get final product, prescription of the present invention is scientific and reasonable, abundant raw material, easily produce, easily take, good effect, cost is low, be a creation on the Chinese materia medica, economic and social benefit is huge.
Four, the specific embodiment
Below in conjunction with practical situation and embodiment the specific embodiment of the present invention is elaborated.
According to such scheme, in force, the present invention constitutes in being incapsulated by Chinese medicine powder, and Chinese medicine powder includes following weight meter:
Agkistrodon 100-150 gram, Radix Angelicae Sinensis 20-60 gram, Radix Clematidis 30-60 gram, Myrrha 20-60 gram, Radix Angelicae Dahuricae 20-60 gram, Radix Puerariae 30-60 gram, eupolyphaga 20-60 gram, Lignum Dalbergiae Odoriferae 20-60 gram, Rhizoma Chuanxiong 20-60 gram, Scolopendra 30-60 gram and Impatientis 30-50 gram are formed.
Chinese medicine powder is producing and can specifically be made up of the following traditional Chinese medicines powder: Agkistrodon 100 grams, Radix Angelicae Sinensis 30 grams, Radix Clematidis 40 grams, Myrrha 30 grams, the Radix Angelicae Dahuricae 30 grams, Radix Puerariae 40 grams, eupolyphaga 30 grams, Lignum Dalbergiae Odoriferae 30 grams, Rhizoma Chuanxiong 30 grams, Scolopendra 35 grams and Impatientis 40 grams.
Chinese medicine powder of the present invention also can be made up of following Chinese medicine powder: Agkistrodon 120 grams, Radix Angelicae Sinensis 40 grams, Radix Clematidis 50 grams, Myrrha 35 grams, the Radix Angelicae Dahuricae 40 grams, Radix Puerariae 45 grams, eupolyphaga 35 grams, Lignum Dalbergiae Odoriferae 40 grams, Rhizoma Chuanxiong 40 grams, Scolopendra 45 grams and Impatientis 45 grams.
Chinese medicine powder of the present invention also can be by following component: Agkistrodon 110 grams, Radix Angelicae Sinensis 25 grams, Radix Clematidis 35 grams, Myrrha 25 grams, the Radix Angelicae Dahuricae 25 grams, Radix Puerariae 35 grams, eupolyphaga 25 grams, Lignum Dalbergiae Odoriferae 25 grams, Rhizoma Chuanxiong 25 grams, Scolopendra 40 grams and Impatientis 35 grams are formed.
In said components, be the raw material of Chinese medicine (or claiming decoction pieces) that cooks by the Chinese medicine processing requirement and be broken into Chinese medicine powder through mixed powder, cross 100 mesh sieves, incapsulate every intragranular 0.5 gram medicated powder.
The present invention also can be made into various dosage forms such as pill, tablet.
Said components, wherein:
Agkistrodon: belong to the snakelet of Elapidae animal Agkistrodon, remove the dedust bits, cutting is dispeled the wind, collateral dredging, relieving convulsion;
Radix Angelicae Sinensis: remove impurity, clean, run through, shave dries or cold drying, enriches blood and invigorates blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation;
Radix Clematidis: for the dry root and rhizome of cohosh Wheeling side, Clematis hexapetala or northeast clematis, remove impurity, clean, run through, cut off drying, expelling wind and removing dampness, removing obstruction in the collateral to relieve pain;
Myrrha: for the colloidal resin that Burseraceae myrrh dried bark portion oozes out, former medicine is broken into pieces, fried the usefulness of deoiling, promoting blood circulation and stopping pain, detumescence and promoting granulation;
The Radix Angelicae Dahuricae: for the dry root of the samphire Radix Angelicae Dahuricae or Radix angelicae dahuricae, remove impurity, separately size is individual, and slightly infiltration is saturating, cuts sheet, drying, and the wind that looses dehumidifies understand things pain-stopping, detumescence and apocenosis;
Radix Puerariae: for the dry root of legume pueraria lobata, remove impurity, clean, run through, cut sheet, dry, expelling pathogenic factors from muscles for reducing heat promotes the production of body fluid, rash, yang invigorating antidiarrheal;
Eupolyphaga: claim eupolyphoge sinensis, female ground beetle, Eupolyphaga Seu Steleophaga again, after the seizure, put in the boiling water and scald extremely, dry or dry, removing blood stasis with potent drugs blood, reuniting the fractured tendons and bones;
Lignum Dalbergiae Odoriferae: for the heartwood of extend section's plant Lignum Dalbergiae Odoriferae wingceltis trunk and root, remove impurity, be split into fritter, promoting flow of QI and blood, analgesic hemostatic;
Rhizoma Chuanxiong: remove impurity, separately size is slightly steeped and is cleaned, and runs through shave, drying, blood-activating and qi-promoting, wind-expelling pain-stopping;
Scolopendra: claim Gekko Swinhonis, centipede again, scald extremely, dry or dry, pain relieving, detoxifcation with boiling water;
Impatientis: be the herb of Balsaminaceae plant Flos Impatientis, herb is cleaned, and cuts off, and dries, and reducing swelling and alleviating pain dispels the wind, and invigorates blood circulation.
By the said components property of medicine as can be known, the science combination of component of the present invention is coordinated mutually, just in time reaches the purpose of treatment cervical spondylosis, has also obtained sufficient proof through clinical trial, and relevant clinical data is as follows:
One, selects the case standard
All have symptomes complice persons such as dizzy, neck, shoulder, arm, hands pain, numbness clinically all as the standard of selecting case.
Two, diagnostic criteria
Cervical spondylosis is meant the cervical intervertebral disk degeneration and causes spinal cord, nerve, blood vessel pressurized, infringement and the corresponding sings and symptoms that causes, according to the cervical spondylosis pathogenesis, can be divided into 4 types:
1, cervical spondylotic radiculopathy: see at most, because of cervical intervertebral disk is outstanding to proceeds posterolateral, due to stimulation or the pressuring neural root, neck and shoulder pain is often arranged, to upper limb radiation, hand anesthesia is unable, finger is dumb, idol has violent lightning sample sharp pain, the inspection restriction of neck motion, neck muscle tonus, tenderness, the brachial plexus nerve distraction test positive, the test of bearing down on one is positive, and X line, CT, MRI check that visible root compression sheet resembles;
2, cervical spondylotic myelopathy: mainly be due to the compressing spinal cords such as intervertebral disk hernia, vertebral body trailing edge hyperosteogeny form, hypertrophy of ligamentum flavum is ossified, with numb limbs and tense tendons unable, stiff dumb, hold thing and the walking shakiness be cardinal symptom, increase the weight of to occur extremity spastic paralysis, dyspnea and fecal and urinary functions obstacle with the state of an illness, X line, CT, MRI all can show the compression of spinal cord situation;
3, intersection nervous system type cervical spondylosis: can show as the sympathetic activation symptom, as migraine or headache, dizziness, feel sick, vomiting, visual deterioration, platycoria or dwindle, palpitate quickly, hypertension, arrhythmia etc., also can show as sympathetic nerve and suppress symptom, as giddy, dim eyesight, shed tears, nasal obstruction, bradycardia, blood pressure drops etc., inspections such as X line, CT, MRI have the root compression performance;
4, vertebral artery type of cervical spondylosis: due to vertebral artery irriate or pressurized, the vertebral artery pressurized causes cerebral blood supply insufficiency, and a series of symptoms occur, as rotatory or rock vertigo, occipitalia or top occipital headache, the sudden amblyopia that can recover automatically or blind, diplopia; Start up or excuse portion rotates and dampinging off of causing etc.
All disease type diagnosis are how not difficult, elderly patient, and how typical clinical manifestation and X line, CT, MRI, myelography, vertebral arteriography or nuclear medicine inspection etc. can make diagnosis to dissimilar cervical spondylosiss.
Three, therapeutic scheme
Every day 3 times, each 3-4 grain, every 0.5 gram, warm water delivery service, 7-10 days is a course of treatment, can serve on 1-3 month observe the curative effect and carry out statistical disposition, establishes matched group simultaneously, compares observation, the matched group QIANLIE KANG TABLETS.
Four, efficacy assessment standard
Recovery from illness: symptom complete obiteration, no any discomfort symptom;
Effectively: symptom obviously alleviates, or the partial symptoms disappearance, needs to continue treatment;
Invalid: symptom does not have any improvement, even the trend that increases the weight of is arranged.
Five, statistical procedures
Be in hospital and outpatient service 1025 routine patients' statistics through clinical, effective percentage is more than 94%, and wherein the patient man is 715,305 of woman, and the age accounted for 70% more than 40 years old, and established matched group and carry out curative effect and add up, and its situation is:
Curative effect statistical table 1
The disease type Example number (people) Recovery from illness (people) Effectively (people) Invalid (people) Effective percentage (%)
Spondylotic radiculopathy 410 185 209 16 96
Myeloid form 123 49 60 14 89
The intersection nervous system type 184 96 79 9 95
Vertebral artery type 308 123 160 25 92
Amount to 1025 453 508 64 94
Contrast treatment statistical table 2
Group Example number (people) Cure (people) Effectively (people) Invalid (people) Effective percentage (%)
Chinese medicine of the present invention 150 68 people 45% 74 people 49.7% 8 people 5.3% 94.7%
QIANLIE KANG TABLETS 100 41 people 41% 51 people 51% 8 people 8% 92%
Why not very the present invention is better than matched group, and the acomia incumbent reaction of the present invention, and drug safety is remarkably productive.
Six, conclusion
Shown that by above-mentioned situation no matter Chinese medicinal capsule of the present invention all has better curative effect from clinical data and controlled observation situation, up to more than 94%, drug safety is better than existing medicine, and clinical meaning is great, is the new creation on the Chinese materia medica.

Claims (4)

1, a kind of Chinese medicinal capsule for the treatment of cervical spondylosis, be to constitute in incapsulating by Chinese medicine powder, it is characterized in that Chinese medicine powder is following weight meter: Agkistrodon 100-150 gram, Radix Angelicae Sinensis 20-60 gram, Radix Clematidis 30-60 gram, Myrrha 20-60 gram, Radix Angelicae Dahuricae 20-60 gram, Radix Puerariae 30-60 gram, eupolyphaga 20-60 gram, Lignum Dalbergiae Odoriferae 20-60 gram, Rhizoma Chuanxiong 20-60 gram, Scolopendra 30-60 gram and Impatientis 30-50 gram are formed.
2, the Chinese medicinal capsule of treatment cervical spondylosis according to claim 1, it is characterized in that Chinese medicine powder is by the weight meter: Agkistrodon 100 grams, Radix Angelicae Sinensis 30 grams, Radix Clematidis 40 grams, Myrrha 30 grams, the Radix Angelicae Dahuricae 30 grams, Radix Puerariae 40 grams, eupolyphaga 30 grams, Lignum Dalbergiae Odoriferae 30 grams, Rhizoma Chuanxiong 30 grams, Scolopendra 35 grams and Impatientis 40 grams are formed.
3, the Chinese medicinal capsule of treatment cervical spondylosis according to claim 1, it is characterized in that Chinese medicine powder is by the weight meter: Agkistrodon 120 grams, Radix Angelicae Sinensis 40 grams, Radix Clematidis 50 grams, Myrrha 35 grams, the Radix Angelicae Dahuricae 40 grams, Radix Puerariae 45 grams, eupolyphaga 35 grams, Lignum Dalbergiae Odoriferae 40 grams, Rhizoma Chuanxiong 40 grams, Scolopendra 45 grams and Impatientis 45 grams are formed.
4, the Chinese medicinal capsule of treatment cervical spondylosis according to claim 1, it is characterized in that Chinese medicine powder is by the weight meter: Agkistrodon 110 grams, Radix Angelicae Sinensis 25 grams, Radix Clematidis 35 grams, Myrrha 25 grams, the Radix Angelicae Dahuricae 25 grams, Radix Puerariae 35 grams, eupolyphaga 25 grams, Lignum Dalbergiae Odoriferae 25 grams, Rhizoma Chuanxiong 25 grams, Scolopendra 40 grams and Impatientis 35 grams are formed.
CNB2006100484043A 2006-07-14 2006-07-14 Chinese medicine capsule for treating cervical spondylosis Expired - Fee Related CN100459989C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006100484043A CN100459989C (en) 2006-07-14 2006-07-14 Chinese medicine capsule for treating cervical spondylosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006100484043A CN100459989C (en) 2006-07-14 2006-07-14 Chinese medicine capsule for treating cervical spondylosis

Publications (2)

Publication Number Publication Date
CN1899402A true CN1899402A (en) 2007-01-24
CN100459989C CN100459989C (en) 2009-02-11

Family

ID=37655512

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006100484043A Expired - Fee Related CN100459989C (en) 2006-07-14 2006-07-14 Chinese medicine capsule for treating cervical spondylosis

Country Status (1)

Country Link
CN (1) CN100459989C (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1067283C (en) * 1993-12-20 2001-06-20 任建国 Curing bag for hyperosteogeny and its using method

Also Published As

Publication number Publication date
CN100459989C (en) 2009-02-11

Similar Documents

Publication Publication Date Title
CN101703692A (en) Chinese medicinal preparation for treating bone fracture and preparation method thereof
CN101062194A (en) Medicine for treating bone disease and fracture and the preparing method thereof
CN1129130A (en) Medicament for treatment of cervical spondylopathy
CN104147388B (en) Traditional Chinese medicine composition for treating migraine and preparation method thereof
CN1418696A (en) Traditional Chinese medicine prepn. for treating cervical vertebra disease
CN102526482A (en) Traditional Chinese medicine preparation for treating lumbar disc herniation
CN1843421A (en) Rheumatoid disease treating medicine
CN1895593A (en) Medicine for treating acne and its preparation
CN100459989C (en) Chinese medicine capsule for treating cervical spondylosis
CN1253196C (en) Medicine for treating colitis
CN101028492A (en) Chinese preparation for treating hysteromyoma
CN101028451A (en) Chinese medicine for treating tic douloureux
CN101057945A (en) Traditional Chinese medicine for treating digestive cancer and its producing method
CN1903354A (en) Traditional Chinese medicine for treating lumbago and skelalgia
CN1939494A (en) Purge capsules for old person and production thereof
CN104435685A (en) Medicine for treating xerophthalmia and preparation method thereof
CN1544019A (en) Chinese traditional medicine composition for treating arthralgia syndrome of cervical spondylopathy and its preparation
CN102631435A (en) Medicament for treating rheumatoid arthritis
CN1555873A (en) Chinese herbal medicine for treating hypertension
CN107412675A (en) A kind of dissipating bind disappears knurl herbal composite and its preparation method and application
CN100335112C (en) Chinese medicine for treating kidney vacuity lumbar pain and preparation method of its capsule
CN105663707A (en) Adhesive-dispersion type transdermal patch for cervical spondylosis nursing and preparation method of transdermal patch
CN102247584A (en) Traditional Chinese medicine for treating kidney-deficiency vertigo and preparation method thereof
CN1772221A (en) Mastosis treating Chinese medicine
CN1840146A (en) Medicament for treating vitiligo

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090211

Termination date: 20110714